{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:17:23Z","timestamp":1790248643105,"version":"4.1.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T00:00:00Z","timestamp":1640736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011542","name":"Center for Clinical and Translational Science, Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA233046"],"award-info":[{"award-number":["U01CA233046"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2 TR002379"],"award-info":[{"award-number":["KL2 TR002379"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jval.2021.11.1368","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T18:12:07Z","timestamp":1641233527000},"page":"1081-1086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["An Exploratory Analysis of the \u201cWas It Worth It?\u201d Questionnaire as a Novel Metric to Capture Patient Perceptions of Cancer Treatment"],"prefix":"10.1016","volume":"25","author":[{"given":"Gita","family":"Thanarajasingam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Basch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Mead-Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia V.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina L.","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Roydhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren J.","family":"Rogak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amylou C.","family":"Dueck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jval.2021.11.1368_bib1","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","article-title":"Validity and reliability of the US National Cancer Institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"1","author":"Dueck","year":"2015","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.jval.2021.11.1368_bib2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/cncr.31133","article-title":"Validity and usefulness of a single-item measure of patient-reported bother from side effects of cancer therapy","volume":"124","author":"Pearman","year":"2018","journal-title":"Cancer"},{"issue":"23","key":"10.1016\/j.jval.2021.11.1368_bib3","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1200\/JCO.2015.61.6706","article-title":"American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options","volume":"33","author":"Schnipper","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.jval.2021.11.1368_bib4","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/annonc\/mdv249","volume":"26","author":"Cherny","year":"2015","journal-title":"Ann Oncol"},{"issue":"19","key":"10.1016\/j.jval.2021.11.1368_bib7","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1001\/jama.2016.4637","article-title":"Toward a patient-centered value framework in oncology","volume":"315","author":"Basch","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jval.2021.11.1368_bib8","first-page":"11","article-title":"What can phase I clinical trials tell us about quality of life? A pilot study (MC0115)","volume":"1","author":"Atherton","year":"2015","journal-title":"Clin Res Trials"},{"issue":"suppl 15","key":"10.1016\/j.jval.2021.11.1368_bib9","article-title":"Was it worth it (WIWI)? Patient satisfaction with clinical trial participation: results from North Central Cancer Treatment Group (NCCTG) phase III trial N0147","volume":"29","author":"Sloan","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.jval.2021.11.1368_bib10","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.eururo.2018.11.033","article-title":"Cabozantinib versus mitoxantrone-prednisone in symptomatic metastatic castration-resistant prostate cancer: a randomized Phase 3 trial with a primary pain endpoint","volume":"75","author":"Basch","year":"2019","journal-title":"Eur Urol"},{"issue":"25","key":"10.1016\/j.jval.2021.11.1368_bib11","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1200\/JCO.2015.65.5597","article-title":"Phase III study of cabozantinib in previously treated metastatic castration-resistant prostate cancer: COMET-1","volume":"34","author":"Smith","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.jval.2021.11.1368_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2019.3332","article-title":"Assessment of adverse events from the patient perspective in a Phase 3 metastatic castration-resistant prostate cancer clinical trial","volume":"6","author":"Dueck","year":"2020","journal-title":"JAMA Oncol"},{"issue":"2 suppl 3","key":"10.1016\/j.jval.2021.11.1368_bib13","first-page":"73","article-title":"Measuring quality of life in palliative care","volume":"22","author":"Cella","year":"1995","journal-title":"Semin Oncol"},{"issue":"19","key":"10.1016\/j.jval.2021.11.1368_bib15","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1001\/jama.2016.4915","article-title":"Utility of cancer value frameworks for patients, payers, and physicians","volume":"315","author":"Chandra","year":"2016","journal-title":"JAMA"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109830152103223X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109830152103223X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:26:22Z","timestamp":1761096382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109830152103223X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S109830152103223X"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2021.11.1368","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Exploratory Analysis of the \u201cWas It Worth It?\u201d Questionnaire as a Novel Metric to Capture Patient Perceptions of Cancer Treatment","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2021.11.1368","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}